Juha M. Grönroos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Juha M. Grönroos has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Arto Rantala
VTT Technical Research Centre of Finland Ltd., P.O. Box 1000, FI-02044 Espoo, Finland
2 shared publications - Markku M. Haapamäki
Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden
2 shared publications T. J. Nevalainen
Department of Pathology, University of Turku, Turku, Finland
2 shared publicationsAiri Jartti
1 shared publicationAndré Aarnink
1 shared publication- Ari Nissinen
Climate Solutions Unit, Finnish Environment Institute (Syke), Helsinki, Finland
1 shared publication
Latest Publications
- 1 October 2015
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 70 (10) , 619-620
Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis
For well over more than years, it has been thought that acute appendicitis invariably progresses to perforation. This underlies the long-held belief that emergency appendectomy is required when a diagnosis of appendicitis is made. In a study published in1956, mortality was low (0.2%), and recurrent appendicitis occurred in only 14.4% of women with acute appendicitis treated with antibiotic therapy. More recently, 3 randomized clinical trials showed that acute appendicitis can be successfully treated with antibiotics. However, these studies had several methodological challenges including clinical diagnosis of acute appendicitis, choice of antibiotic treatment, unclear determination of the primary end point, and highly restrictive patient selection. Appendectomy has remained the standard approach for treating appendicitis. The aim of the Appendicitis Acuta (APPAC) trial was to compare outcomes of antibiotic therapy and emergency appendectomy in the treatment of uncomplicated acute appendicitis confirmed by a computed tomographic (CT) scan. The hypothesis tested in this large multicenter, open-label randomized trial was that antibiotic treatment of uncomplicated acute appendicitis was noninferior to appendectomy. The study was conducted from November 2009 until June 2012 in 6 Finnish hospitals. Participants were patients aged 18 to 60 years who had been admitted to the emergency department with a suspicion of uncomplicated acute appendicitis confirmed by a CT scan. Subjects were randomized either to undergo open appendectomy or to receive antibiotic therapy with intravenous ertapenem administered as a single, daily dose (1 g/d) for 3 days followed by 7 days of oral levofloxacin (500 mg once daily) and metronidazole (500 mg 3 times per day). Successful completion of an appendectomy was the primary end point for the surgical intervention. For patients treated with antibiotics, the primary end point was resolution of acute appendicitis without the need for surgery and no recurrent appendicitis during a follow-up of 1 year. A total of 273 patients were randomized to receive the surgical intervention and 257 to receive antibiotic therapy. All but 1 patient in the surgical group underwent successful appendectomy; the success rate was 99.6% (95% confidence interval [CI], 98.0%–100.0%). Within 1 year of initial presentation for appendicitis, 27.3% (70/256) of the patients in the antibiotic group (95% CI, 22.0%–33.2%) underwent appendectomy. Of the 256 patients in the antibiotic group available for the 1-year follow-up, 186 (72.7%; 95% CI, 66.8%–78.0%) did not require appendectomy. In intention-to-treat analysis, the difference in treatment efficacy between groups was −27.0% (95% CI, −31.6% to ∞; (P = 0.89). Because the prespecified noninferiority margin between groups was 24%, noninferiority of antibiotic treatment relative to surgery was not demonstrated. Among the 70 patients randomized to antibiotic treatment who subsequently had undergone appendectomy during the 1-year follow-up, 58 (82.9%; 95% CI, 72.0%–90.8%) had uncomplicated appendicitis, 7 (10.0%; 95% CI, 4.1%–19.5%) had complicated acute appendicitis, and 5 (7.1%; 95% CI, 2.4%–15.9%) who did not have appendicitis received appendectomy for suspected recurrence. None of the patients treated initially with antibiotics who required delayed appendectomy had an intra-abdominal abscess or other major complications. Antibiotic treatment for CT-proven, uncomplicated appendicitis failed to meet the prespecified criterion for noninferiority compared with appendectomy. However, most patients with uncomplicated appendicitis treated with antibiotics did not require appendectomy during the 1-year follow-up, and those who subsequently required appendectomy experienced no significant complications. Future studies should focus on early identification of patients with complicated acute appendicitis needing surgery and prospective evaluation of the optimal use of antibiotic treatment in uncomplicated cases.
- 1 October 2015
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 70 (10) , 619-620
Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis
For well over more than years, it has been thought that acute appendicitis invariably progresses to perforation. This underlies the long-held belief that emergency appendectomy is required when a diagnosis of appendicitis is made. In a study published in1956, mortality was low (0.2%), and recurrent appendicitis occurred in only 14.4% of women with acute appendicitis treated with antibiotic therapy. More recently, 3 randomized clinical trials showed that acute appendicitis can be successfully treated with antibiotics. However, these studies had several methodological challenges including clinical diagnosis of acute appendicitis, choice of antibiotic treatment, unclear determination of the primary end point, and highly restrictive patient selection. Appendectomy has remained the standard approach for treating appendicitis. The aim of the Appendicitis Acuta (APPAC) trial was to compare outcomes of antibiotic therapy and emergency appendectomy in the treatment of uncomplicated acute appendicitis confirmed by a computed tomographic (CT) scan. The hypothesis tested in this large multicenter, open-label randomized trial was that antibiotic treatment of uncomplicated acute appendicitis was noninferior to appendectomy. The study was conducted from November 2009 until June 2012 in 6 Finnish hospitals. Participants were patients aged 18 to 60 years who had been admitted to the emergency department with a suspicion of uncomplicated acute appendicitis confirmed by a CT scan. Subjects were randomized either to undergo open appendectomy or to receive antibiotic therapy with intravenous ertapenem administered as a single, daily dose (1 g/d) for 3 days followed by 7 days of oral levofloxacin (500 mg once daily) and metronidazole (500 mg 3 times per day). Successful completion of an appendectomy was the primary end point for the surgical intervention. For patients treated with antibiotics, the primary end point was resolution of acute appendicitis without the need for surgery and no recurrent appendicitis during a follow-up of 1 year. A total of 273 patients were randomized to receive the surgical intervention and 257 to receive antibiotic therapy. All but 1 patient in the surgical group underwent successful appendectomy; the success rate was 99.6% (95% confidence interval [CI], 98.0%–100.0%). Within 1 year of initial presentation for appendicitis, 27.3% (70/256) of the patients in the antibiotic group (95% CI, 22.0%–33.2%) underwent appendectomy. Of the 256 patients in the antibiotic group available for the 1-year follow-up, 186 (72.7%; 95% CI, 66.8%–78.0%) did not require appendectomy. In intention-to-treat analysis, the difference in treatment efficacy between groups was −27.0% (95% CI, −31.6% to ∞; (P = 0.89). Because the prespecified noninferiority margin between groups was 24%, noninferiority of antibiotic treatment relative to surgery was not demonstrated. Among the 70 patients randomized to antibiotic treatment who subsequently had undergone appendectomy during the 1-year follow-up, 58 (82.9%; 95% CI, 72.0%–90.8%) had uncomplicated appendicitis, 7 (10.0%; 95% CI, 4.1%–19.5%) had complicated acute appendicitis, and 5 (7.1%; 95% CI, 2.4%–15.9%) who did not have appendicitis received appendectomy for suspected recurrence. None of the patients treated initially with antibiotics who required delayed appendectomy had an intra-abdominal abscess or other major complications. Antibiotic treatment for CT-proven, uncomplicated appendicitis failed to meet the prespecified criterion for noninferiority compared with appendectomy. However, most patients with uncomplicated appendicitis treated with antibiotics did not require appendectomy during the 1-year follow-up, and those who subsequently required appendectomy experienced no significant complications. Future studies should focus on early identification of patients with complicated acute appendicitis needing surgery and prospective evaluation of the optimal use of antibiotic treatment in uncomplicated cases.
- Open Access
- 1 September 2011
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 100 (3) , 164-168
Adoption of Single Incision Laparoscopic Cholecystectomy in Small-Volume Hospitals: Initial Experiences of 51 Consecutive Procedures
Laparoscopic cholecystectomy (LC) via three or four ports has been the standard operation for gallstone disease. Recently, the development of multichannel port devices has allowed LCs to be performed through a single fascial incision in the umbilicus. Here, we report our experiences of the adoption of the single incision laparoscopic cholecystectomy (SILC) in two small-volume community hospitals. From January until July 2010, 51 consecutive patients (41 females and 10 males, the mean age 44 (21–75) years, BMI 26 (18–35)) underwent elective SILC for symptomatic gallstone disease in Salo (n = 29) and Loimaa (n = 22) hospitals. Of the 51 operations, 42 (82%) were accomplished without additional troacars. Seven (14%) procedures were converted to multiple-port technique and two (4%) to open cholecystectomy. In 25 (49%) operations, transabdominal retraction sutures through the gallbladder were used to maintain a good view of the triangle of Calot. The mean operative time was 74 (31–155) min. No major intraoperative complications occurred. The mean hospital stay was 0.6 (0–3) days. During a mean follow up of 4 (1–7) months, five (10%) patients had wound infection, and one (2%) had hematoma and prolonged pain in the insertion site of the retraction suture. One (2%) patient was reoperated for continuous pain in umbilical wound without findings at operation but with good results. One (2%) patient had subphrenic abscess seven months postoperatively. Our initial experiences indicate that SILC can be adopted without major complications in small-volume hospitals but the rate of wound infections seems to increase with the introduction of SILC.
- 1 September 2011
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 100 (3) , 164-168
Open AccessAdoption of Single Incision Laparoscopic Cholecystectomy in Small-Volume Hospitals: Initial Experiences of 51 Consecutive Procedures
Laparoscopic cholecystectomy (LC) via three or four ports has been the standard operation for gallstone disease. Recently, the development of multichannel port devices has allowed LCs to be performed through a single fascial incision in the umbilicus. Here, we report our experiences of the adoption of the single incision laparoscopic cholecystectomy (SILC) in two small-volume community hospitals. From January until July 2010, 51 consecutive patients (41 females and 10 males, the mean age 44 (21–75) years, BMI 26 (18–35)) underwent elective SILC for symptomatic gallstone disease in Salo (n = 29) and Loimaa (n = 22) hospitals. Of the 51 operations, 42 (82%) were accomplished without additional troacars. Seven (14%) procedures were converted to multiple-port technique and two (4%) to open cholecystectomy. In 25 (49%) operations, transabdominal retraction sutures through the gallbladder were used to maintain a good view of the triangle of Calot. The mean operative time was 74 (31–155) min. No major intraoperative complications occurred. The mean hospital stay was 0.6 (0–3) days. During a mean follow up of 4 (1–7) months, five (10%) patients had wound infection, and one (2%) had hematoma and prolonged pain in the insertion site of the retraction suture. One (2%) patient was reoperated for continuous pain in umbilical wound without findings at operation but with good results. One (2%) patient had subphrenic abscess seven months postoperatively. Our initial experiences indicate that SILC can be adopted without major complications in small-volume hospitals but the rate of wound infections seems to increase with the introduction of SILC.
- 4 May 2011
- Published by S. Karger AG in Digestive Surgery
- Vol. 28 (3) , 205-209
Elective Laparoscopic Cholecystectomy: The Effect of Age on Conversions, Complications and Long-Term Results
Background/Aims: The purpose of the present study was to analyze the appropriateness and long-term results of elective laparoscopic cholecystectomy in the treatment of gallstone disease in the elderly. Methods: We studied all elderly (≧75 years) patients (n = 80) who underwent laparoscopic cholecystectomy at our institution during the years 1992–2001. Two control groups (65–74 years and <65 years) included the same amount of patients. For determining the long-term results, we asked the patients to specify their overall satisfaction with the results of the procedure (very satisfied, satisfied, no effect, worse). Results: There were no statistically significant differences in mean operative time (61, 65, 72 min) or conversions to open surgery (6, 11, 16%) between the age groups (<65, 65–74, ≧75 years). The mean hospitalization time (2.1, 3.3, 4.4 days) and complications (0, 11, 13%) increased with the age of the patients. Neither severe complications nor mortality were encountered. The vast majority of the patients were very satisfied or satisfied with the long-term results of the procedure in all age groups (97% <65 years, 83% 65–74 years, 80% ≧75 years). Conclusion: Elective laparoscopic cholecystectomy is also a safe and feasible operation with good long-term results in the elderly.
- 4 May 2011
- Published by S. Karger AG in Digestive Surgery
- Vol. 28 (3) , 205-209
Elective Laparoscopic Cholecystectomy: The Effect of Age on Conversions, Complications and Long-Term Results
Background/Aims: The purpose of the present study was to analyze the appropriateness and long-term results of elective laparoscopic cholecystectomy in the treatment of gallstone disease in the elderly. Methods: We studied all elderly (≧75 years) patients (n = 80) who underwent laparoscopic cholecystectomy at our institution during the years 1992–2001. Two control groups (65–74 years and <65 years) included the same amount of patients. For determining the long-term results, we asked the patients to specify their overall satisfaction with the results of the procedure (very satisfied, satisfied, no effect, worse). Results: There were no statistically significant differences in mean operative time (61, 65, 72 min) or conversions to open surgery (6, 11, 16%) between the age groups (<65, 65–74, ≧75 years). The mean hospitalization time (2.1, 3.3, 4.4 days) and complications (0, 11, 13%) increased with the age of the patients. Neither severe complications nor mortality were encountered. The vast majority of the patients were very satisfied or satisfied with the long-term results of the procedure in all age groups (97% <65 years, 83% 65–74 years, 80% ≧75 years). Conclusion: Elective laparoscopic cholecystectomy is also a safe and feasible operation with good long-term results in the elderly.
- 1 January 2007
- Published by Elsevier in Journal of Cleaner Production
- Vol. 15 (6) , 538-549
Developing benchmarks for consumer-oriented life cycle assessment-based environmental information on products, services and consumption patterns
- 1 January 2007
- Published by Elsevier in Journal of Cleaner Production
- Vol. 15 (6) , 538-549
Developing benchmarks for consumer-oriented life cycle assessment-based environmental information on products, services and consumption patterns
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 66 (7) , 585-594
Value of blood tests including serum group IIA phospholipase A2and bactericidal/permeability‐increasing protein in Crohn's disease
Objective. Determination of the activity of Crohn's disease at a defined time‐point is a challenging task since only endoscopy guidelines are given and secondary clinical findings, subjective symptoms and non‐specific laboratory tests have therefore to be relied on. The purpose of the current study was to investigate the ability of blood tests to differentiate patient groups with different clinical disease activity and different clinical outcomes during follow‐up in Crohn's disease. Material and methods. During a visit to hospital, 73 outpatients with Crohn's disease were examined, a clinical score was calculated and blood samples were collected for 22 laboratory tests. The patients were also grouped according to clinical outcome during a 6‐year follow‐up. Results. Serum group IIA phospholipase A2 and α‐1‐antitrypsin values were outside the reference interval more frequently (62% and 42%, respectively) than the other tests in active Crohn's disease. Only weak correlations were found between the clinical score and the test values, and the best correlation was found with serum lysozyme (r = 0.40). In a logistic regression model, the best prediction of disease activity at entry to the study was reached with a model including serum orosomucoid and serum lysozyme and the best prediction of clinical outcome during follow‐up was reached using a model including serum albumin. Conclusions. Serum group IIA phospholipase A2 appeared to be the most sensitive marker of inflammation in Crohn's disease among the 22 blood tests compared. No reliable predictions of disease activity at the time of blood sampling or clinical outcome later during follow‐up could be made from the blood tests studied.
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 66 (7) , 585-594
Value of blood tests including serum group IIA phospholipase A2and bactericidal/permeability‐increasing protein in Crohn's disease
Objective. Determination of the activity of Crohn's disease at a defined time‐point is a challenging task since only endoscopy guidelines are given and secondary clinical findings, subjective symptoms and non‐specific laboratory tests have therefore to be relied on. The purpose of the current study was to investigate the ability of blood tests to differentiate patient groups with different clinical disease activity and different clinical outcomes during follow‐up in Crohn's disease. Material and methods. During a visit to hospital, 73 outpatients with Crohn's disease were examined, a clinical score was calculated and blood samples were collected for 22 laboratory tests. The patients were also grouped according to clinical outcome during a 6‐year follow‐up. Results. Serum group IIA phospholipase A2 and α‐1‐antitrypsin values were outside the reference interval more frequently (62% and 42%, respectively) than the other tests in active Crohn's disease. Only weak correlations were found between the clinical score and the test values, and the best correlation was found with serum lysozyme (r = 0.40). In a logistic regression model, the best prediction of disease activity at entry to the study was reached with a model including serum orosomucoid and serum lysozyme and the best prediction of clinical outcome during follow‐up was reached using a model including serum albumin. Conclusions. Serum group IIA phospholipase A2 appeared to be the most sensitive marker of inflammation in Crohn's disease among the 22 blood tests compared. No reliable predictions of disease activity at the time of blood sampling or clinical outcome later during follow‐up could be made from the blood tests studied.
- 4 June 2002
- Published by Wiley in Electrophoresis
- Vol. 23 (11) , 1667-1676
mRNA differential display of gene expression in colonic carcinoma
We analyzed changes in gene expression in human colonic carcinoma by fluorescent mRNA differential display. RNA isolated from two samples of normal colon and four cases of colonic adenocarcinoma were amplified with a 15×32 set of primers resulting in 2880 cDNAs analyzed with an automated sequencer. Electrophoretic patterns implying constitutive gene expression as well as upregulated and downregulated expression in carcinomas were identified. Forty such cDNA fragments were purified by a novel fluorescent polyacrylamide gel electrophoresis (PAGE)‐based method and identified by cyclic sequencing. Most genes showing differential expression were upregulated in colonic carcinoma. Upregulated genes included those for various ribosomal and mitochondrial proteins, heat shock proteins, nucleolar RNA‐helicase and phosphoserine aminotransferase. Downregulated genes included histone H3.3. In conclusion, genes associated with vital cellular functions such as transcription, protein synthesis and mitochondrial metabolism were upregulated in colonic carcinoma. Fluorescent mRNA differential display can be applied to the identification of novel cancer‐related genes for diagnostic, prognostic and therapeutic purposes.
- 4 June 2002
- Published by Wiley in Electrophoresis
- Vol. 23 (11) , 1667-1676
mRNA differential display of gene expression in colonic carcinoma
We analyzed changes in gene expression in human colonic carcinoma by fluorescent mRNA differential display. RNA isolated from two samples of normal colon and four cases of colonic adenocarcinoma were amplified with a 15×32 set of primers resulting in 2880 cDNAs analyzed with an automated sequencer. Electrophoretic patterns implying constitutive gene expression as well as upregulated and downregulated expression in carcinomas were identified. Forty such cDNA fragments were purified by a novel fluorescent polyacrylamide gel electrophoresis (PAGE)‐based method and identified by cyclic sequencing. Most genes showing differential expression were upregulated in colonic carcinoma. Upregulated genes included those for various ribosomal and mitochondrial proteins, heat shock proteins, nucleolar RNA‐helicase and phosphoserine aminotransferase. Downregulated genes included histone H3.3. In conclusion, genes associated with vital cellular functions such as transcription, protein synthesis and mitochondrial metabolism were upregulated in colonic carcinoma. Fluorescent mRNA differential display can be applied to the identification of novel cancer‐related genes for diagnostic, prognostic and therapeutic purposes.
- 1 January 2002
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 62 (2) , 123-128
Source of group II phospholipase A 2 in gastric juice
Gastric juice contains both pancreatic group I phospholipase A2 (PLA2-I) and synovial-type group II phospholipase A2 (PLA2-II), which may play a crucial role in Helicobacter pylori infection and gastric mucosal injury. PLA2-I present in gastric juice is derived from pancreatic acinar cells. The cellular source of PLA2-II found in gastric juice is unknown. A specific cell type of the intestinal mucosa, the Paneth cell, is known to secrete PLA2-II. The purpose of the present study was to define the source of PLA2-II present in gastric juice. For this purpose, gastric juice was collected from 29 individuals during gastroscopy, and mucosal biopsies were taken from the antrum and body of the stomach and from the duodenum as well as from the jejunum of individuals with resected stomach, for immunohistochemical detection of PLA2-II. The concentration of bilirubin in the gastric juice samples was determined to identify duodenogastric regurgitation. The PLA2-II content was significantly higher in bilirubin-positive than in bilirubin-negative gastric juice samples. PLA2-II was localized by immunohistochemistry in Paneth cells in three patients with areas of intestinal metaplasia of the gastric mucosa and in Paneth cells of duodenal and jejunal mucosa in all patients, but not in any other epithelial cell type of the mucosa of the stomach or the small intestine. Inflammatory cells did not contain PLA2-II. The current results suggest that PLA2-II found in gastric juice is derived from the Paneth cells of the small intestinal mucosa.
- 1 January 2002
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 62 (2) , 123-128
Source of group II phospholipase A 2 in gastric juice
Gastric juice contains both pancreatic group I phospholipase A2 (PLA2-I) and synovial-type group II phospholipase A2 (PLA2-II), which may play a crucial role in Helicobacter pylori infection and gastric mucosal injury. PLA2-I present in gastric juice is derived from pancreatic acinar cells. The cellular source of PLA2-II found in gastric juice is unknown. A specific cell type of the intestinal mucosa, the Paneth cell, is known to secrete PLA2-II. The purpose of the present study was to define the source of PLA2-II present in gastric juice. For this purpose, gastric juice was collected from 29 individuals during gastroscopy, and mucosal biopsies were taken from the antrum and body of the stomach and from the duodenum as well as from the jejunum of individuals with resected stomach, for immunohistochemical detection of PLA2-II. The concentration of bilirubin in the gastric juice samples was determined to identify duodenogastric regurgitation. The PLA2-II content was significantly higher in bilirubin-positive than in bilirubin-negative gastric juice samples. PLA2-II was localized by immunohistochemistry in Paneth cells in three patients with areas of intestinal metaplasia of the gastric mucosa and in Paneth cells of duodenal and jejunal mucosa in all patients, but not in any other epithelial cell type of the mucosa of the stomach or the small intestine. Inflammatory cells did not contain PLA2-II. The current results suggest that PLA2-II found in gastric juice is derived from the Paneth cells of the small intestinal mucosa.
- 1 January 1994
- Published by Springer Nature
- p. 253-261
Detection of Phospholipases A2 in Serum in Acute Pancreatitis
- 1 January 1994
- Published by Springer Nature
- p. 253-261
Detection of Phospholipases A2 in Serum in Acute Pancreatitis